A fast and easy way to find out about all new FDA approved cancer treatments.
Wednesday, November 13, 2013
Ibrutinib for Mantle Cell Lymphoma
Ibrutinib (Imbruvica) has been FDA approved for the treatment of mantle cell lymphoma who have received at least one prior therapy.
Tuesday, November 5, 2013
New treatment for CLL
Gazyva (obinutuzumab) now approved for use in combination with chlorambucil for previously untreated CLL patients (chronic lymphocytic leukemia).
Subscribe to:
Posts (Atom)